Insider · CIK 0002086036
Choon Wee Chee
Files at HSDT (HELIUS MEDICAL TECHNOLOGIES, INC.). First filing -, latest -.
In brief
Choon Wee Chee files SEC Form 4 as chair, director, 10% owner, CEO and president at HSDT (HELIUS MEDICAL TECHNOLOGIES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Choon Wee Chee has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | HSDT HELIUS MEDICAL TECHNOLOGIES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +923,000 | $0.00 | $0 | 923,000 | Aug 4, 2026 |
| May 11, 2026 | HSDT HELIUS MEDICAL TECHNOLOGIES, INC. | MOption exercise Class A Common Stock | +1,109,118 | $0.00 | $0 | 1,109,118 | May 13, 2026 |
| Sep 18, 2025 | HSDT HELIUS MEDICAL TECHNOLOGIES, INC. | AGrant or award Strategic Advisory Warrantsderivativeindirect: By Summer Wisdom Holdings Limited | +2,218,236 | $0.00 | $0 | 2,218,236 | May 13, 2026 |
| May 11, 2026 | HSDT HELIUS MEDICAL TECHNOLOGIES, INC. | MOption exercise Restricted Stock Unit Awardderivative | -1,109,118 | $0.00 | $0 | 0 | May 13, 2026 |
Questions about Choon Wee Chee
Answered from the filings on this page, as of the latest one.
Is Choon Wee Chee buying or selling?
Choon Wee Chee has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Choon Wee Chee's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Choon Wee Chee has 0.
Where does Choon Wee Chee file Form 4?
Choon Wee Chee has filed Form 4 at HSDT (HELIUS MEDICAL TECHNOLOGIES, INC.) as CEO and President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.